Jupiter Topco’s Evolent Health EVH Stock Holding History

Jupiter Topco’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.97M	Buy	+364,129	New	+$1.4M	﹤0.01%	1472

Other funds holding EVH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco's EVH Position: Q2 2026 in Review

Jupiter Topco opened a new position in Evolent Health (EVH) in Q2 2026: 364,129 shares worth $1.97M. The stake represents ﹤0.01% of the portfolio and ranks #1472 among its holdings.

176 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

Jupiter Topco held 364,129 shares of Evolent Health worth $1.97M as of Q2 2026.
Evolent Health was a new Jupiter Topco position in Q2 2026.
Evolent Health made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #1472 holding.
176 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.